OCUL · Forms 3, 4, 5
Insider trades at OCULAR THERAPEUTIX, INC
3 insiders sold $234K of OCULAR THERAPEUTIX, INC stock on the open market in the last 30 days.
Every Form 3, 4 and 5 filed for OCULAR THERAPEUTIX, INC (OCUL) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Insider trades in the last 90 days
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Todd Anderman | Chief Legal Officer | Sell | 11,984 | $7.29 | $87K | Form 4 | |
| Peter Kaiser | Chief Development Officer | Sell | 9,990 | $7.05 | $70K | Form 4 | |
| Jeffrey S. Heier | Chief Scientific Officer | Sell | 10,869 | $7.05 | $77K | Form 4 | |
| Donald Notman | Chief Operating Officer | Sell | 1,099 | $10.24 | $11K | Form 4 | |
| Pravin Dugel | See Remarks | Gift | 50,092 | Form 4 | |||
| Pravin Dugel | See Remarks | Gift | 50,092 | Form 4 | |||
| Peter Kaiser | Chief Development Officer | Sell | 3,035 | $10.77 | $33K | Form 4 | |
| Sanjay Nayak | Chief Strategy Officer | Sell | 1,897 | $10.78 | $20K | Form 4 | |
| Jeffrey S. Heier | Chief Scientific Officer | Sell | 3,296 | $10.78 | $36K | Form 4 | |
| Pravin Dugel | See Remarks | Sell | 21,649 | $10.77 | $233K | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.